Parental education and the WHO neonatal G-6-PD screening program: A quarter century later

Journal of Perinatology

Volumn 35, Issue 10, 2015, Pages 779-784

  Kaplan, M ^a   Hammerman, C ^a,b   Bhutani, V K ^c  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b SHAARE ZEDEK MEDICAL CENTER   (Israel)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; GLUCOSE 6 PHOSPHATE DEHYDROGENASE;

ADULT; ARTICLE; AUDIOVISUAL EQUIPMENT; CLINICAL ASSESSMENT; DIETARY INTAKE; EDUCATION; ENVIRONMENTAL FACTOR; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HEALTH CARE PERSONNEL; HEALTH PROGRAM; HEMOLYSIS; HIGH RISK POPULATION; HUMAN; HYPERBILIRUBINEMIA; INCIDENCE; JAUNDICE; KERNICTERUS; MATERNAL WELFARE; NEUROTOXICITY; NEWBORN; NEWBORN PERIOD; NEWBORN SCREENING; PARENTAL EDUCATION; SEPSIS; WORLD HEALTH ORGANIZATION; BLOOD; FEMALE; GLUCOSEPHOSPHATE DEHYDROGENASE DEFICIENCY; JAUNDICE, NEONATAL; MALE; PARENT; PRACTICE GUIDELINE; TRENDS;

BILIRUBIN; FEMALE; GLUCOSEPHOSPHATE DEHYDROGENASE; GLUCOSEPHOSPHATE DEHYDROGENASE DEFICIENCY; HEMOLYSIS; HUMANS; INFANT, NEWBORN; JAUNDICE, NEONATAL; KERNICTERUS; MALE; NEONATAL SCREENING; PARENTS; PRACTICE GUIDELINES AS TOPIC; WORLD HEALTH ORGANIZATION;

EID: 84942982054     PISSN: 07438346     EISSN: 14765543     Source Type: Journal    
DOI: 10.1038/jp.2015.77     Document Type: Article

References (47)

1. Beutler E. G6PD deficiency. Blood 1994; 84(11): 3613-3636.
2. Cappellini MD, Fiorelli G. Glucose-6-phosphate dehydrogenase deficiency. Lancet 2008; 371(9606): 64-74.
3. Olusanya BO, Emokpae AA, Zamora TG, Slusher TM. Addressing the burden of neonatal hyperbilirubinaemia in countries with significant glucose-6-phosphate dehydrogenase deficiency. Acta Paediatr (e-pub ahead of print; doi:10.1111/apa.12735).
4. Johnson L, Bhutani VK, Karp K, Sivieri EM, Shapiro SM. Clinical report from the pilot USA Kernicterus Registry (1992 to 2004). J Perinatol 2009; 29(Suppl1): S25-S45.
5. Sgro M, Campbell D, Shah V. Incidence and causes of severe neonatal hyperbilirubinemia in Canada. CMAJ 2006; 175(6): 587-590.
6. Manning D, Todd P, Maxwell M, Jane Platt M. Prospective surveillance study of severe hyperbilirubinaemia in the newborn in the UK and Ireland. Arch Dis Child Fetal Neonatal Ed 2007; 92(5): F342-F346.
7. WHO Working Group. Glucose-6-phosphate dehydrogenase deficiency. Bull World Health Organ 1989; 67(6): 601-611.
8. Nkhoma ET, Poole C, Vannappagari V, Hall SA, Beutler E. The global prevalence of glucose-6-phosphate dehydrogenase deficiency: a systematic review and meta-analysis. Blood Cells Mol Dis 2009; 42(3): 267-278.
9. Howes RE, Piel FB, Patil AP et al. G6PD deficiency prevalence and estimates of affected populations in malaria endemic countries: a geostatistical modelbasedmap. PLoS Med 2012; 9(11): e1001339.
10. Monteiro WM, Val FF, Siqueira AM, Franca GP, Sampaio VS, Melo GC et al. G6PD deficiency in Latin America: systematic review on prevalence and variants. Mem Inst Oswaldo Cruz 2014; 109(5): 553-568.
11. Bhutani VK, Zipursky A, Blencowe H, Khanna R, Sgro M, Ebbesen F et al. Neonatal hyperbilirubinemia and Rhesus disease of the newborn: incidence and impairment estimates for 2010 at regional and global levels. Pediatr Res 2013; 74 (Suppl 1): 86-100.
12. Arain YH, Bhutani VK. Prevention of Kernicterus in South Asia: role of neonatal G6PD deficiency and its identification. Indian J Pediatr 2014; 81(6): 599-607.
13. Kaplan M, Hammerman C. Glucose-6-phosphate dehydrogenase deficiency and severe neonatal hyperbilirubinemia: a complexity of interactions between genes and environment. Semin Fetal Neonatal Med 2010; 15(3): 148-156.
14. Kaplan M, Hammerman C. Neonatal screening for glucose-6-phosphate dehydrogenase deficiency: biochemical versus genetic technologies. Semin Perinatol 2011; 35(3): 155-161.
15. Slusher TM, Vreman HJ, McLaren DW, Lewison LJ, Brown AK, Stevenson DK. Glucose-6-phosphate dehydrogenase deficiency and carboxyhemoglobin concentrations associated with bilirubin-related morbidity and death in Nigerian infants. J Pediatr 1995; 126(1): 102-108.
16. Nair PA, Al Khusaiby SM. Kernicterus and G6PD deficiency-a case series from Oman. J Trop Pediatr 2003; 49(2): 74-77.
17. Mallouh AA, Imseeh G, Abu-Osba YK, Hamdan JA. Screening for glucose-6-phosphate dehydrogenase deficiency can prevent severe neonatal jaundice. Ann Trop Paediatr 1992; 12(4): 391-395.
18. Ogunlesi TA, Dedeke IO, Adekanmbi AF, Fetuga MB, Ogunfowora OB. The incidence and outcome of bilirubin encephalopathy in Nigeria: a bi-centre study. Niger J Med 2007; 16(4): 354-359.
19. Al-Naama LM, Al-Sadoon IA, Al-Naama MM. Neonatal jaundice and glucose-6-phosphate dehydrogenase deficiency in Basrah. Ann Trop Paediatr 1987; 7(2): 134-138.
20. Du L, Ma X. International perspectives: hyperbilirubinemia and kernicterus in neonates in China. NeoReviews 2012; 13: e141-e144.
21. Kaplan M, Hammerman C. The need for neonatal glucose-6-phosphate dehydrogenase screening: a global perspective. J Perinatol 2009; 29(Suppl 1): S46-S52.
22. Watchko JF, Kaplan M, Stark AR, Stevenson DK, Bhutani VK. Should we screen newborns for glucose-6-phosphate dehydrogenase deficiency in the United States? J Perinatol 2013; 33(7): 499-504.
23. American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2004; 114(1): 297-316.
24. Russell JC, Smith S, Novales W, Massi Lindsey LL, Hanson J. Use of the extended parallel processing model to evaluate culturally relevant kernicterus messages. J Pediatr Health Care 2013; 27(1): 33-40.
25. Waldrop JB, Anderson CK, Brandon DH. Guideline-based educational intervention to decrease the risk for readmission of newborns with severe hyperbilirubinemia. J Pediatr Health Care 2013; 27(1): 41-50.
26. Ezeaka CV, Ugwu RO, Mukhtar-Yola M, Ekure EN, Olusanya BO. Pattern and predictors of maternal care-seeking practices for severe neonatal jaundice in Nigeria: a multi-centre survey. BMC Health Serv Res 2014; 14: 192.
27. Lau HK, Li CH, Lee AC. Acute massive haemolysis in children with glucose-6-phosphate dehydrogenase deficiency. Hong Kong Med J 2006; 12(2): 149-151.
28. Khneisser I, Adib SM, Loiselet J, Megarbane A. Cost-benefit analysis of G6PD screening in Lebanese newborn males. J Med Leban 2007; 55(3)):129-132.
29. Padilla CD, Therrell BL. Newborn screening in the Asia Pacific region. J Inherit Metab Dis 2007; 30(4): 490-506.
30. Jiang J, Li B, Cao W, Jiang X, Jia X, Chen Q et al. Screening and prevention of neonatal glucose 6-phosphate dehydrogenase deficiency in Guangzhou, China. Genet Mol Res 2014; 13(2): 4272-4279.
31. Missiou-Tsagaraki S. Screening for glucose-6-phosphate dehydrogenase deficiency. J Pediatr 1992; 121(1): 165-166.
32. Missiou-Tsagaraki S. Screening for glucose-6-phosphate dehydrogenase deficiency as a preventive measure: prevalence among 1,286,000 Greek newborn infants. J Pediatr 1991; 119(2): 293-299.
33. Lin Z, Fontaine JM, Freer DE, Naylor EW. Alternative DNA-based newborn screening for glucose-6-phosphate dehydrogenase deficiency. Mol Genet Metab 2005; 86(1-2): 212-219.
34. Genetic Alliance, District of Columbia Department of Health. Newborn Screening, in Understanding Genetics. A Guide for Parents and Health Professionals. Chapter 4. Posted in the Resource Repository at http://www.resourcerepository.org/documents/1869/understandinggenetics:adistrictofco lumbiaguideforpatientsandhealthprofessionals/.
35. Nock ML, Johnson EM, Krugman RR, Di Fiore JM, Fitzgerald S, Sandhaus LM et al. Implementation and analysis of a pilot in-hospital newborn screening program for glucose-6-phosphate dehydrogenase deficiency in the United States. J Perinatol 2011; 31(2): 112-117.
36. Meloni T, Forteleoni G, Meloni GF. Marked decline of favism after neonatal glucose-6-phosphate dehydrogenase screening and health education: the northern Sardinian experience. Acta Haematol 1992; 87(1-2): 29-31.
37. Meloni T, Cagnazzo G, Dore A, Cutillo S. Phenobarbital for prevention of hyperbilirubinemia in glucose-6-phosphate dehydrogenase-deficient newborn infants. J Pediatr 1973; 82(6): 1048-1051.
38. Lam ST, Cheng ML. Neonatal screening in Hong Kong and Macau. Southeast Asian J Trop Med Public Health 2003; 34(Suppl 3): 73-75.
39. Joseph R, Ho LY, Gomez JM, Rajdurai VS, Sivasankaran S, Yip YY. Mass newborn screening for glucose-6-phosphate dehydrogenase deficiency in Singapore. Southeast Asian J Trop Med Public Health 1999; 30(Suppl 2): 70-71.
40. Joseph R. Mass newborn screening in Singapore-position and projections. Ann Acad Med Singapore 2003; 32(3): 318-323.
41. Algur N, Avraham I, Hammerman C, Kaplan M. Quantitative neonatal glucose-6-phosphate dehydrogenase screening: distribution, reference values, and classification by phenotype. J Pediatr 2012; 161(2): 197-200.
42. Riskin A, Gery N, Kugelman A, Hemo M, Spevak I, Bader D. Glucose-6-phosphate dehydrogenase deficiency and borderline deficiency: association with neonatal hyperbilirubinemia. J Pediatr 2012; 161(2): 191-196.
43. Bhutani VK, Johnson L, Sivieri EM. Predictive ability of a predischarge hour-specific serum bilirubin for subsequent significant hyperbilirubinemia in healthy term and near-term newborns. Pediatrics 1999; 103(1): 6-14.
44. Kaplan M, Bromiker R, Schimmel MS, Algur N, Hammerman C. Evaluation of discharge management in the prediction of hyperbilirubinemia: the Jerusalem experience. J Pediatr 2007; 150(4): 412-417.
45. Newborn Screening Authoring Committee (E. Stephen Edwards, MD, Chairperson). Newborn screening expands: recommendations for pediatricians and medical homes-implications for the system. Pediatrics 2008; 121(1): 192-217.
46. Smith-Greenaway E. Mothers' reading skills and child survival in Nigeria: examining the relevance of mothers' decision-making power. Soc Sci Med 2013; 97: 152-160.
47. Kuzniewicz MW, Wickremasinghe AC, Wu YW, McCulloch CE, Walsh EM, Wi S et al. Incidence, etiology, and outcomes of hazardous hyperbilirubinemia in newborns. Pediatrics 2014; 134(3): 504-509.